Cite
HARVARD Citation
Sattar, N. et al. (2021). Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials. Lancet. 9 (10), pp. 653-662. [Online].